HSIC vs PATH
Henry Schein Inc (HSIC) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported HSIC revenue for 2024-12-28 was $12.67B. Net income was $398.0M. Revenue was up 2.7% from 2023-12-30 to 2024-12-28. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the HSIC and PATH stock pages for the full models.
Not investment advice.